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ABOUT THE HEALTH POLICY COMMISSION
The HPC, established in 2012, is an independent state agency charged with monitor-
ing health care spending growth in Massachusetts and providing data-driven policy 
recommendations regarding health care delivery and payment system reform. The 
HPC’s mission is to advance a more transparent, accountable, and innovative health 
care system through independent policy leadership and investment programs.
The agency’s main responsibilities are led by HPC staff and overseen by an 11-member 
Board of Commissioners. HPC staff and commissioners work collaboratively to monitor 
and improve the performance of the health care system. Key activities include setting the 
health care cost growth benchmark; monitoring provider and payer performance relative 
to the health care cost growth benchmark; creating standards for care delivery systems 
that are accountable to better meet patients’ medical, behavioral, and health-related 
social needs; analyzing the impact of health care market transactions on cost, quality, 
and access; and investing in community health care delivery and innovations.
HISTORY OF THE OFFICE OF PATIENT PROTECTION
Prior to 1990, only two states had external review programs for denials of health insur-
ance claims. In 1998, former Governor Paul Cellucci signed Executive Order No. 405 
creating the Office of the Managed Care Ombudsman to provide assistance to managed 
care consumers. Two years later, the Office of Patient Protection (OPP) was established 
through Chapter 141 of the Acts of 2000, a law that created new protections for health 
insurance consumers. In January 2001, the Office of the Managed Care Ombudsman 
merged with OPP. OPP operated within the Department of Public Health from 2000 
until Chapter 224 of the Acts of 2012 transferred OPP from the Department of Public 
Health to the newly established Health Policy Commission, effective April 20, 2013. 
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Introduction
Entering its eighteenth year, the Office of Patient Protec-
tion (OPP), operated by the Massachusetts Health Policy 
Commission (HPC), is responsible for regulating and admin-
istering certain health care consumer protections for the 
Commonwealth. OPP is a resource for individuals who 
want to become more informed and empowered health care 
consumers. This annual report provides a comprehensive 
overview of activities of the Office.
KEY RESPONSIBILITIES OF THE OFFICE OF 
PATIENT PROTECTION
OPP safeguards the rights of health care consumers by 
regulating the internal grievance process and administering 
external reviews for consumers with fully-insured Mas-
sachusetts health plans and patients of certain provider 
organizations, administering health insurance enrollment 
waivers, and providing information and education about 
health insurance concerns to the public. The core respon-
sibilities of OPP are:
• Regulating the internal review process for consumers 
who wish to challenge denials of coverage by health plans
• Regulating and administering the external review pro-
cess for consumers who seek an independent appeal to 
challenge adverse determinations issued by health plans
• Administering an enrollment waiver process for consum-
ers who wish to purchase non-group health insurance
• Regulating the internal appeals process for commercially 
insured patients of Risk-bearing Provider Organizations 
(RBPO) and HPC-certified Accountable Care Organi-
zations (ACO)
• Regulating and administering the external review process 
for patients of RBPOs and ACOs who seek an indepen-
dent appeal regarding a provider’s decision on referrals 
and other concerns
• Examining, analyzing, and reporting on certain infor-
mation and data received annually from Massachusetts 
health plans
• Providing training, education, and responding to con-
sumer inquiries about health insurance appeal rights, 
open enrollment waivers, and other issues related to 
health coverage and services
NOTABLE UPDATES IN 2018
Collected New Health Plan Reporting: Under new author-
ity, OPP, in coordination with the Division of Insurance 
(DOI), has begun to collect claims denial data from ful-
ly-insured health plans. The additional reporting is intended 
to provide greater transparency, broaden the data currently 
reported to OPP, and supplement information submitted to 
the DOI. Throughout 2018, OPP worked collaboratively 
with the DOI and health plans to refine reporting guidelines 
for the collection of 2018 claims data. The guidelines require 
reporting of the number of professional, institutional as well 
as laboratory claims in the categories of medical/surgical, 
mental health, or substance use disorder and the number of 
claims approved or denied in each category and the reasons 
for denial. The health plans submitted 2018 data to OPP 
and the DOI in July 2019. OPP continues to work with the 
DOI and the health plans to analyze the data and consider 
dissemination approaches.
Issued Regulation and Implemented New External Review 
Process: Following a multiyear stakeholder engagement 
process, including a public hearing and comment period, 
OPP issued the final regulation on RBPO and ACO appeals 
on September 7, 2018. Under the regulation, RBPOs and 
ACOs administer internal appeals for patients and report to 
OPP annually on the number of appeals received and their 
outcomes. OPP is implementing an external review process 
for patients who remain aggrieved following an internal 
appeal. To correspond with the release of the regulation and 
extended consumer protections, staff updated OPP webpages 
to provide consumer-facing information about RBPO/ACO 
appeals including answers to frequently asked questions 
and guidance on how to submit an external review request.
Issued Guidance: Pursuant to MGL c. 6D, section 16, 
health plans’ medical necessity criteria must be made avail-
able upon request to members, prospective members, health 
care providers, OPP and the Division of Insurance. Medical 
necessity criteria are the policies and protocols that health 
plans use to determine whether certain services should be 
provided to members, based on clinical evidence. OPP’s 
2018 Bulletin requested all health plans submit any new 
or updated criteria to OPP by June 2018. Following that 
initial submission, OPP further requested that health plans 
provide prompt updates on any new or revised criteria no 
later than 30 days from the date of its implementation.
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Contracting Update: By regulation, OPP must contract 
with at least three accredited external review agencies. In 
March 2018, OPP initiated a competitive procurement pro-
cess with a Request for Responses (RFR) for external review 
agencies to perform clinical reviews for the health insurance 
and RBPO/ACO external review processes. 10 external 
review agencies responded to the RFR. After reviewing 
responses, OPP chose four external review agencies to serve 
OPP for an initial three year term that began in July 2018.
OPP Operations: OPP provides a “no wrong door” 
approach for consumers and other stakeholders requesting 
assistance with health care and coverage concerns. To that 
end, OPP staff continues to implement improvements to 
internal operations while strengthening statewide stake-
holder relations. Throughout the year, the team responded 
to over 1,820 inquiries via its toll-free hotline. In 2018, most 
callers had inquiries about enrolling in health insurance 
through requesting an open enrollment waiver. In 2018, 
OPP experienced a transition in leadership, with Nancy K. 
Ryan assuming the role of Director of OPP in September.
Enrollment Waivers
Federal and state law limit when individuals and families 
can buy certain health insurance plans. Most Massachusetts 
consumers must buy insurance during a designated open 
enrollment period. Massachusetts residents who missed 
the previous open enrollment period, and have not expe-
rienced a qualifying life event, may qualify for a waiver of 
the open enrollment period if they meet certain criteria. 
The Office of Patient Protection reviews waiver requests 
and typically grants open enrollment waivers to individuals 
and families who:
• Are uninsured and did not intentionally forgo enrollment 
in health insurance, or
• Lost insurance coverage but did not find out until after 
60 days had passed
2018 ENROLLMENT WAIVER DATA
During 2018, the Office of Patient Protection received 840 
requests for waivers from Massachusetts residents seeking to 
buy insurance from the Health Connector or directly from 
an insurance company or insurance agent. Upon review, 
i  CHIA Enrollment Trends (August 2019). 
OPP issued 642 waivers to eligible applicants or 76% of 
all received requests (Figure 1). In 2018, OPP received 
double the amount of waiver requests than in previous 
years. While there is not one specific factor driving this 
increase, it may be due to increasing statewide enrollment 
in individual health insurance plans and a greater awareness 
of the open enrollment waiver process.i OPP also provided 
guidance to consumers who had difficulty enrolling in a 
health plan. Since the waiver process cannot resolve all health 
plan enrollment issues for uninsured consumers, OPP staff 
triaged concerns and provided information and referrals to 
other agencies or organizations as needed.
Year Total Waiver Applications
2011 276
2012 576
2013 416
2014 316
2015 562
2016 355
2017 389
2018 840
Source: 2011-2018 Office of Patient Protection waiver data.
FIGURE 1
24%
76%
Denied
Approved 840
Source: 2018 Office of Patient Protection waiver data.
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Health Insurance Appeals
Under Massachusetts law,ii health care consumers have 
the right to appeal certain decisions by their health plans. 
This essential consumer protection provides an economical 
and fair process to resolve disputes between members and 
their health plan. These laws apply to individuals with 
“fully-insured” Massachusetts health plans (see Glossary for 
definitions). Consumers with other types of health plans, 
including self-insured plans, MassHealth (Medicaid), or 
Medicare, have different appeal rights under other state 
or federal laws.
INTERNAL REVIEW
When an insurer informs a consumer that the health plan 
will not pay for the consumer’s medical or behavioral health 
treatment, the consumer may appeal that decision by first 
contacting the health plan. This first appeal, often called a 
member grievance, is an internal review by the health plan. 
The consumer may seek an expedited internal review for 
urgent matters. Otherwise, the health plan must respond to 
the consumer within 30 calendar days, unless both parties 
agree, in writing, to an extension. The health plan may 
uphold the original decision, or it may change its decision 
and cover all or part of the insured’s treatment.
2018 INTERNAL REVIEW DATA
During 2018, Massachusetts health insurance companies 
reported 13,416 member grievances (Figure 2). These 
ii  M.G.L. c. 176O §§ 13-14.
grievances include many different types of member com-
plaints, such as disputes over coverage for treatment or 
cost-sharing.
Figure 3 shows the member grievances reported by each 
health insurance company that provided fully-insured 
coverage in Massachusetts during 2018. As in past years, 
insurers with more members have more appeals. In order 
to compare health insurance company practices, OPP also 
analyzed the number of grievances filed per number of health 
plan members, to come up with a “weighted average” that 
gives a better indication of which insurers have the highest 
numbers of grievances relative to their total membership.
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FIGURE 3
Source: 2018 insurance carrier reports to 
the Office of Patient Protection, pursuant 
to 958 CMR 3.600; CHIA Enrollment Trends 
(August 2019). 
Notes: Weighted by dividing number of 
internal reviews by an average of 2018 
health plan member data reported quar-
terly to CHIA. 
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FIGURE 2
Source: 2018 insurance carrier reports to the Office of Patient Protection, 
pursuant to 958 CMR 3.600.
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Under current OPP regulations, health plans report detailed 
information about the types and outcomes of member 
grievances received. For 2018, health plans reported the 
following figures:
• Member grievances: Health insurers resolved 48% or 
6,444 of all member grievances fully or partly in favor 
of the member.
• Medical necessity denials: 5,558 or 41% of internal 
grievances resulted from adverse determinations by the 
health plan, which are denials of coverage based on 
health plan medical necessity decisions.
• Behavioral Health: Of the 5,558 grievances based on 
medical necessity, 12% or 640 involved behavioral health 
treatment.
• Pursuing external review: Of those grievances denied 
based on medical necessity, 12% of patients or consumers 
sought an independent external review of the health 
plan’s final adverse determination (Figure 4). While this 
number may seem low, it is consistent with prior year 
trends, indicating that a significant portion of consumers 
are aware of their appeal rights and are exercising them, 
and yet some opportunities for consumer engagement 
remain.
EXTERNAL REVIEW
After a health plan’s internal appeals process is 
exhausted, the insurance provider is required 
by law to allow for an external appeal. The 
process offers health care consumers the 
opportunity to obtain an independent review 
when a health plan denies coverage as not 
medically necessary or as experimental or 
investigational; such notice is often referred 
to as a final adverse determination. If a con-
sumer pursues an internal review and the 
health insurer upholds its original decision, 
the consumer may have the right to pursue an 
external review. An external review is a second 
level of appeal, conducted by an organiza-
tion independent from the consumer’s health 
plan. Health insurance companies may deny 
services prospectively (such as prior autho-
rizations), retrospectively, or concurrently 
(during the course of treatment). External 
review is only available when the health plan’s 
iii  958 CMR 3.020.
determination was based on whether the specific treatment 
or service at issue was medically necessary, including whether 
the health plan determined that the service was experimental 
or investigational.
WHAT IS MEDICAL NECESSITY? 
Health insurance companies that are licensed to do 
business in Massachusetts must pay for medical 
services and treatments that are covered bene-
fits under the health plan and that are medically 
necessary. Health insurers may develop their own 
standards for deciding when care is medically 
necessary. Massachusetts law defines medical 
necessity in the following way:
Medical Necessity or Medically Necessary means 
health care services that are consistent with gen-
erally accepted principles of professional medical 
practice as determined by whether the service:
a) is the most appropriate available supply or level 
of service for the insured in question considering 
potential benefits and harms to the individual;
b) is known to be effective, based on scientific evi-
dence, professional standards and expert opinion, 
in improving health outcomes; or
c) for services and interventions not in widespread 
use, is based on scientific evidence.iii
OPP External 
Appeals
Denied Internal 
Reviews
Total Internal Reviews 
Based on an Adverse 
Determination
44% 
Denied
88% 
No further 
action
12% 
12% 
of denied internal reviews 
sought an external appeal 
through OPP
56% 
In favor of 
consumer
FIGURE 4
Source: 2018 Office of Patient Protection external review data; 2018 insurance carrier 
reports to the Office of Patient Protection, pursuant to 958 CMR 3.600. In Favor of 
Consumer includes Approved, Partially Approved, and Withdrawn or Resolved.
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ELIGIBILITY FOR EXTERNAL 
REVIEW THROUGH THE OFFICE OF 
PATIENT PROTECTION
Requests must be eligible for external review. An insurance 
dispute is usually eligible for external review through OPP 
if all of the following are met:
• The health insurance company is licensed in the 
Commonwealth
• The insurance product is a fully-insured health insur-
ance plan
• The patient’s request for external review includes one 
of these:
 { A final adverse determination, OR
 { An adverse determination, if the patient is seeking 
an expedited internal review and expedited external 
review at the same time, OR
 { A written confirmation that insurance company has 
waived internal review
• The final adverse determination or adverse determination 
is based on medical necessity
• Request for external review filed with OPP within four 
(4) months of the date from when the patient received the 
final adverse determination (final denial by health plan)
• Request for external review is in writing and on the 
external review request form issued by OPP
OPP makes every effort to assist consumers in finalizing 
applications that are missing necessary information in their 
filed request. A request is considered incomplete if requisite 
application components are missing like attestations or 
signatures. The most common reasons for external reviews to 
be deemed ineligible in 2018 were the consumer requesting 
external review was covered under a self-insured plan and 
the request concerned a benefit that was explicitly excluded 
from coverage.
EXTERNAL REVIEW PROCESS
When OPP receives an eligible request for external review, 
the request is randomly assigned to one of four external 
review agencies, also known as independent review organiza-
tions, which have agreed to avoid conflicts of interest. These 
external review agencies are not government agencies. They 
are private companies with panels of doctors and medical 
experts who work in different fields and are located through-
out the country. In 2018, the Health Policy Commission 
contracted with four nationally accredited, independent 
external review agencies; they were:
• Independent Medical Experts Consulting Services, Inc. 
(IMEDECS), based in Lansdale, Pennsylvania
• Island Peer Review Organization (IPRO), based in Lake 
Success, New York
• MAXIMUS Federal Services, Inc., based in Pittsford, 
New York
• ProPeer Resources, LLC, based in New Braunfels, Texas
After receiving the OPP case file (which includes the exter-
nal review request form, denial notices from the insurer, 
and any additional information submitted by the patient), 
the external review agency assigns it to one or more of its 
medical experts who practice in the same or similar specialty 
as the service in dispute. The medical expert then reviews 
the information submitted by the insurance company and 
the patient, and reaches an independent conclusion about 
whether the treatment or service is medically necessary for 
the patient.
In accordance with state law, the external review agency issues 
its decision within 45 days for standard external reviews 
and within 72 hours for expedited external reviews. The 
decision of the external review agency is final and binding, 
though other legal rights apart from OPP’s external review 
process may be available.
The consumer who requests external review usually pays a 
$25 fee toward the cost of the review. Upon request, OPP 
may waive the $25 fee due to financial hardship; no con-
sumer is required to pay more than $75 in fees per year. If 
a consumer prevails on external review and the decision is 
overturned, OPP refunds the $25 fee to the consumer. The 
insurer pays the external review agency for most or all of 
the external review, a cost which can range from $475 to 
$2,250 depending on the time frame for the review, type 
of review, and the number of reviewers needed.
In making a decision, the external clinical reviewer considers 
the determination of the health plan, medical records of 
the patient, comments from a treating provider, and other 
pertinent documents to determine medical necessity. An 
external appeal decision is issued to all parties in writing 
and is subject to the terms and conditions of the insured’s 
coverage with the health plan, such as cost sharing require-
ments, or maximum benefit limitations.
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2018 EXTERNAL REVIEW DATA
For each calendar year, the HPC analyzes overall external 
review data and further delineates its analysis by medical/
surgical and behavioral health data.
EXTERNAL REVIEW CASES AND RESULTS 
FOR 2018
During 2018, OPP screened 302 external review requests 
for eligibility. 231 or 76% of these requests were deemed 
eligible for external review. Of the eligible cases, 37% were 
overturned in whole or in part or modified by the external 
review agency in favor of the patient. Approximately 5% 
of the eligible cases were resolved between the patient and 
the insurer or withdrawn before a final determination was 
issued by an external review agency. The external review 
agencies upheld the remainder of the cases, which accounted 
for 58% of cases eligible for review.
Figure 5 illustrates the dispositions or results for all eligible 
external reviews filed during 2018. Figure 6 breaks down 
the total number of external reviews into two categories: 
medical or surgical care and behavioral health.
Figure 7 compares the frequency of eligible external reviews 
for each health plan. This number is calculated by adjusting 
the total number of external reviews for each plan by the 
number of members reported by each health plan in 2018. 
This analysis identifies an average for the number of external 
reviews filed by all fully-insured health plan members. Of 
the state’s health plans with the most fully-insured mem-
bers, identified in Figure 7, three had a rate of external 
review above the statewide average, with Fallon reporting 
the highest proportion.
MEDICAL/SURGICAL DATA
OPP received 195 eligible external review requests involving 
medical or surgical services. This category encompasses 
appeals involving a broad range of medical care, including 
imaging, lab testing, pharmacy requests, and infertility 
treatment. External review data for behavioral health services 
are explored further below.
In 2018, 59% of external reviews involving medical or 
surgical treatment upheld the decision of the health insurer 
and 37% of reviews were resolved either fully or partially 
in favor of the patient (Figure 8). 4% of external reviews 
involving medical or surgical treatment were resolved prior 
to an issued decision. The most common medical/surgical 
review requests were in the categories of outpatient care 
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Source: 2018 Office of Patient Protection external review data.
Source: 2018 Office of Patient Protection external review data.
Source: 2018 Office of Patient Protection external review data; CHIA Enroll-
ment Trends (August 2019). 
Note: Weighted by dividing number of eligible external reviews by an average 
of 2018 health plan member data reported quarterly to CHIA.
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and pharmacy. OPP received 74 external review requests 
regarding outpatient medical/surgical care including surger-
ies, medical visits, and rehabilitation services, 59 of which 
were eligible for external review.
Additionally, 31 requests were received for pharmacy treat-
ments, of which 24 were eligible for external review. Of 
the 24 matters in this category that were eligible for review, 
11 were overturned or partially overturned by the external 
review agency.
During 2018, OPP received 24 external review requests 
involving infertility treatment. Out of the 19 eligible cases, 
14 were upheld by the external review agency. 4 eligible 
cases were overturned by the external review agency, while 
1 case was resolved by the health insurance company prior 
to the issuance of a decision.
EXPERIMENTAL AND 
INVESTIGATIONAL SERVICES
OPP provides consumers with the right to obtain an inde-
pendent review by a panel of clinical experts when health 
plans consider services to be experimental or investigational. 
In 2018, OPP received 32 eligible external review requests 
involving services deemed to be experimental or investi-
gational by the insurance companies. This is nearly triple 
the amount received in 2017 and 2016. Diagnostic cancer 
screenings accounted for 11 out of the 32 cases received, and 
in all of those cases the ERA upheld the insurer’s original 
decision. Other requests included non-standard surgical 
procedures or treatments. Overall, 10 of the experimental/
investigation requests were overturned in favor of the patient 
and 21 were upheld (1 was resolved by the health insurance 
company prior to the issuance of a decision).
OUT OF NETWORK COVERAGE REQUESTS
In some instances, a consumer has the right to appeal a denial 
of coverage for treatment by a provider who is outside of the 
insurer’s network. If the treatment is a covered service, and 
if the insurer denied coverage because it was not medically 
necessary to receive the services from an out of network 
provider, then the consumer may request external review. 
OPP determines whether such matters are eligible for review 
on a case-by-case basis. If eligible, the reviewer then decides 
whether the treatment is medically necessary and if so, could 
any in-network provider perform the procedure or provide 
the service at issue.
During 2018, OPP received 33 requests for external review 
involving coverage for an out of network provider. 18 of 
these were eligible for external review and 8 were resolved 
in favor of the patient.
BEHAVIORAL HEALTH
OPP received fewer external review requests pertaining to 
behavioral health services than in years past. Behavioral 
health services include treatment for mental health con-
ditions, substance use disorders, and some developmental 
disabilities in 2018.
OPP received 43 requests for external review of behavioral 
health services during 2018, and 36 of these were eligible 
for external review.
Eligible behavioral health cases: Of all eligible behavioral 
health cases received during 2018, 15 cases were fully or par-
tially overturned in favor of the patient. Half of the eligible 
behavioral health cases were resolved in the patient’s favor.
Mental health treatment: Of the eligible cases, OPP 
received 20 requests for mental health treatment. Inpa-
tient or residential mental health care represents the largest 
subcategory, with 11 eligible requests for external review.
Substance use disorder treatment: OPP received 9 eligible 
requests for treatment related to substance use disorders; 8 of 
which were for residential or inpatient substance use disorder 
treatment. Of the 9 eligible cases regarding substance use 
disorder, 4 were overturned or partially overturned by an 
independent medical reviewer because care was found to 
be medically necessary.
Other: OPP received 7 eligible requests for other behavioral 
health services, primarily requests for therapies to treat 
developmental disabilities.
FIGURE 8
Source: 2018 Office of Patient Protection external review data.
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HEALTH INSURANCE APPEALS OVERVIEW
In general, a consumer who receives an adverse determina-
tion from an insurance company, denying coverage based 
on medical necessity grounds, has a significant chance of 
modifying or overturning the decision through the appeals 
process. According to figures reported to OPP by health 
plans, 58% of members who received adverse determinations 
from their health plans were able to have their disputes 
partially or fully resolved in their favor through the internal 
review or external review process.
The numbers of external review requests filed during 2018, 
and the numbers of reviews deemed eligible, were largely 
consistent with recent years. However, 2018 saw a lower 
overall number of requests for reviews of behavioral health 
services and treatments. Consistent with past years, a higher 
proportion of external reviews for behavioral health services 
were resolved in favor of the consumer than external reviews 
for medical/surgical services. In 2018, 50% of behavioral 
health external reviews were resolved in favor of the consumer, 
compared to 41% of reviews for medical or surgical services.
Appeals Process for Patients of 
Accountable Care Organizations 
(ACO) and Risk-bearing Provider 
Organizations (RBPO)
Under Massachusetts lawiv, OPP is responsible for adminis-
tering a first in the nation consumer protection for patients 
of HPC-certified Accountable Care Organizations (ACO) 
and Risk-bearing Provider Organizations (RBPO). This 
new consumer protection provides an opportunity for 
patients attributed to an ACO or RBPO to appeal provider 
determinations about referral restrictions or other potential 
limitations of care. This process is available for patients with 
commercial health insurance only; Medicare or MassHealth 
(Medicaid) patients have separate appeal rights.
INTERNAL APPEAL
RBPOs and ACOs are comprised of health care providers 
who work together to coordinate patient care and enter into 
financial arrangements with health plans to do so. Patients 
may have disagreements with their health care providers 
about the care that they are receiving. For example, a health 
care provider may refer a patient to a certain specialist within 
the RBPO or ACO, but the patient prefers to see another 
iv  M.G.L. c. 176O, § 24; M.G.L. c. 6D, §§ 15 and 16.
specialist affiliated with a separate provider group due to past 
medical history. By requesting an internal appeal, the patient 
is asking the RBPO or ACO to reconsider the health care 
provider’s decision about that referral. Patients may appeal 
issues related to referrals, the type or intensity of services, 
the timeliness of care available within the RBPO or ACO, 
or other issues related to RBPO/ACO financial incentives. 
The RBPO or ACO must resolve the appeal in writing 
within 14 calendar days of receiving the request. If there is 
an urgent medical need, the RBPO or ACO must resolve 
the appeal within 3 business days. The RBPO or ACO may 
uphold the original decision, or it may change the decision 
and provide the referral or requested treatment or service.
2018 RBPO/ACO INTERNAL APPEAL DATA
OPP collected a full year of data on internal appeals in 2018. 
Over the course of the year, the provider organizations 
reporting to OPP administered a total of 55 internal appeals. 
Of those 55, 67% upheld the initial decision by the ACO or 
RBPO (Figure 9). Figure 10 shows that the vast majority 
of the internal appeals, 76%, concerned referral restrictions. 
The next largest category of internal appeals, accounting 
for 24%, concerned the type or intensity of treatment or 
33%
67%
Appeals 
Overturned
Appeals
Upheld
FIGURE 9
Source: 2018 Office of Patient Protection ACO/RBPO appeals data.
Type/IntensityReferral
76%
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45%
FIGURE 10
Source: 2018 Office of Patient Protection ACO/RBPO appeals data.
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services recommended by the ACO or RBPO. In the course 
of reporting, ACOs and RBPOs also submitted a copy of 
the patient notice used by the ACO or RBPO to notify 
patients about this process, standards or guidelines used to 
review appeals, and information about the individual at the 
ACO or RBPO charged with reviewing appeals.
EXTERNAL REVIEW
If the RBPO/ACO upholds the health care provider’s denial 
of the requested referral, treatment, or service, the patient 
may request an external review of that decision through OPP. 
The external review process offers patients the opportunity 
to obtain an independent review of a health care decision. 
OPP began implementing the external review process on 
September 7, 2018, the effective date of the final regulation. 
OPP did not receive any requests for external review from 
September 2018 through the end of the year.
Requests must be eligible for external review. A request is 
usually eligible for external review through OPP if all of 
the following are met:
• The patient receives care from a health care provider 
within an ACO or RBPO
• The patient has a commercial health insurance plan for 
which the ACO or RBPO is at some financial risk
• The patient submitted the request for external review 
within 30 days of the date the patient received written 
notice of the internal appeal decision
• The request for external review is in writing and on the 
external review request form issued by OPP
• The request includes a copy of the written determination 
letter issued by the RBPO or ACO
EXTERNAL REVIEW PROCESS
The RBPO/ACO external review process mirrors the health 
insurance external review process, described on page 5, 
with a few minor differences. Just as in the health insurance 
external review process, when OPP receives an eligible 
request for external review, the request is randomly assigned 
to one of the four contracted external review agencies. The 
external review agency assigns the case to one of its medical 
experts who practices in the same or similar specialty as the 
service in dispute.
The medical expert then reviews the information submitted 
by the ACO or RBPO and the patient and reaches an inde-
pendent conclusion about whether the requested referral 
treatment or service is likely to produce a more clinically 
beneficial outcome for the patient than the referral, treat-
ment or service recommended by the RBPO or ACO. This 
standard is different than in the health insurance external 
review process. In making a decision, the external clinical 
reviewer must consider the following factors: the patient’s 
clinical history, including prior clinical relationships; the 
availability, within the RBPO or ACO, of a health care 
professional with the appropriate training and experience to 
meet the particular health care needs of the patient, including 
timely access; generally accepted principles of professional 
medical practice; the efficacy of the requested treatment or 
service, based on scientific evidence, professional standards 
and expert opinion, in improving health outcomes; and 
other factors considered relevant to the patient’s ability to 
access the requested referral, treatment, or service.
The external clinical reviewer uses medical records provided 
by the patient and the RBPO or ACO and other pertinent 
documents to determine whether the patient’s request is 
likely to produce a more clinically beneficial outcome. An 
external review decision, including an analysis of medical 
evidence and an explanation of the decision, is issued to 
all parties in writing within 21 days for standard external 
reviews and within 72 hours for expedited external reviews. 
The decision of the external review agency is final and bind-
ing, though other legal rights apart from OPP’s external 
review process may be available.
The RBPO or ACO pays the external review agency for 
the external review, a cost which can range from $475 to 
$750 depending on the time frame for the review. Unlike 
the health insurance external review process, the RBPO or 
ACO patient does not pay a fee to request an external review.
Health Care Consumer Protections
HEALTH PLAN REPORTING
Massachusetts fully-insured health plans submit annual 
reports to the Office of Patient Protection, providing infor-
mation about the following:
• Internal reviews
• External reviews
• Sources of information about consumer satisfaction
• Rates of provider disenrollment and reasons for 
disenrollment
• Medical loss ratio
• Claims and claim denials
• Other health plan information
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OPP works with other agencies and seeks input from stake-
holders, like health insurance companies and consumer 
groups, to implement Massachusetts health insurance laws. 
Where inter-agency questions or concerns arise, OPP works 
closely with the Massachusetts Division of Insurance, the 
Office of the Attorney General, the Health Connector, the 
Office of Medicaid, and other state and federal agencies 
to address concerns, minimize duplicative efforts, reduce 
regulatory burden, and ensure compliance.
CONSUMER INFORMATION 
AND ASSISTANCE
The Office of Patient Protection serves as a resource for 
consumers, through our hotline, website, and educational 
guides. OPP assists with questions about health insurance 
appeals, enrollment waivers, and other health care problems 
through our hotline, at 800-436-7757. Telephone translation 
services are available for callers who speak non-English 
languages or for those who are hearing impaired; staff is also 
accessible by email or by fax. On our website at http://www.
mass.gov/hpc/opp, consumers can find relevant forms in 
English and Spanish, instructions for pursuing an external 
review or requesting an enrollment waiver, reports, and 
answers to frequently asked questions.
TRAINING AND OUTREACH
OPP welcomes requests for informational presentations from 
consumer organizations, health care providers, government 
agencies, and other interested groups. Staff is available to 
provide trainings and to answer questions. To request a 
training session, contact OPP at HPC-OPP@mass.gov or 
at 1-800-436-7757.
2
Since its inception, the Office of Patient Protection has 
worked effectively to safeguard health care consumer protec-
tions in the Commonwealth. OPP has continued to solicit 
and act on feedback and promote awareness of external 
appeal and waiver rights. OPP strives to address each inquiry, 
waiver, and appeal in a fair and consistent manner. OPP’s 
efforts contribute to the provision of high quality patient 
care while advancing a more transparent, accountable, and 
innovative health care system.
I cannot say enough about how much my son and I 
appreciate all that you have done to help us out at this 
difficult time. We fully recognize and appreciate the role 
you play for patients like my son who need advocacy and 
support with major insurers. It shouldn’t have to be this 
way —- but knowing you are out there to help makes 
a huge difference. Thank you from the bottom of our 
hearts. You really made a difference.
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Glossary
EXTERNAL REVIEW 
AGENCY
An independent third-party medical review resource that provides objective med-
ical determinations based on evidence that includes medical reports, health plan 
guidelines, and evidence-based criteria. Each review agency offers a panel of clinical 
providers to review appeals fairly and impartially. ERAs are required to be accredited 
by URAC or another nationally recognized accrediting entity.
FULLY-INSURED A health insurance plan purchased by an individual, a family, an employer, or another 
entity. The purchaser of the health insurance plan pays premiums to the insurance 
company and, in return, the insurance company pays the claims for certain health 
care services. Fully-insured plans can be regulated by the state government. This 
is also referred to as fully-funded.
HEALTH PLAN In this report, a “health plan” refers to an insurance product or insurance plan 
offered by a health insurance company.
MEDICAL NECESSITY OR 
MEDICALLY NECESSARY
Refers to health care services that are consistent with generally accepted principles 
of professional medical practice as determined by whether the service:
• is the most appropriate available supply or level of service for the insured in 
question considering potential benefits and harms to the individual;
• is known to be effective, based on scientific evidence, professional standards 
and expert opinion, in improving health outcomes; or
• for services and interventions not in widespread use, is based on scientific evidence.
NON-GROUP INSURANCE Non-group insurance means health insurance that you buy for yourself or your 
family from the Health Connector or from an insurance company or insurance agent.
OPEN ENROLLMENT Under Massachusetts and federal law there are only certain times during the year 
when individuals and families may buy non-group health insurance coverage. The 
time when individuals and families can apply – the time when health insurers 
open plans to new members – is called “open enrollment.” This is similar to the 
process employers use to allow their employees to sign up or change plans during 
specific times.
SELF-INSURED/
SELF-FUNDED
Under a self-insured or self-funded plan, your employer pays the costs for its 
employees’ health care directly instead of paying premiums to buy health insurance. 
Some self-insured employers hire insurance companies to process the paperwork 
and it may be difficult to discern if a plan is self-funded. Contact your employer 
to find out if your plan is self-insured. Self-insured plans are usually regulated by 
the federal government and governed by “ERISA” or the Employee Retirement 
Income Security Act of 1974.
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